Clinical Trials Directory

Trials / Completed

CompletedNCT05166980

Study of Multiply-fortified Salt Among Women of Reproductive Age and Preschool Children in India

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,389 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
12 Months – 49 Years
Healthy volunteers
Accepted

Summary

Micronutrient (MN) deficiencies are highly prevalent in India, particularly among women of reproductive age (WRA) and preschool aged children (PSC). MN fortification of a staple food or condiment can be an effective strategy for improving the MN status of nutritionally vulnerable populations, as the approach is cost-effective, utilizes existing delivery systems, can deliver multiple MNs simultaneously, and does not require behavior change by the population. Salt is a particularly attractive vehicle for multiple MN fortification in India, as it is universally consumed in fairly consistent amounts; and 93% of households already use adequately iodized salt. The overall goal of this study is to evaluate the nutritional impact of quintuply-fortified salt with iron in the form of FePP (FePP-Q5S, i.e. salt fortified with iron in the form of ferric pyrophosphate plus ethylenediaminetetraacetic acid as an enhancer of absorption; zinc in the form of zinc oxide; vitamin B12; folic acid; and iodine) vs. quintuply-fortified salt with iron in the form of eFF (eFF-Q5S i.e. salt fortified with iron in the form of encapsulated ferrous fumarate; zinc in the form of zinc oxide, vitamin B12, folic acid, and iodine) vs. iodized salt (IS) for the improvement of micronutrient status among nonpregnant WRA and preschool-aged children (12-59 months of age) in Punjab, India. Enrolled women (and their affiliated households) will be randomized to receive 1 kg of their assigned study salt per month for 12 months, and will be instructed to use the study salt in place of their usual salt. Blood and urine samples will be collected from participant WRA and PSC at enrollment, 6 months and at the end of the 12-month intervention period. The change in the mean concentration of various MN biomarkers will be considered primary outcomes. Stool samples will also be collected from a subgroup of women and children to assess changes in the gut microbiome over the intervention period.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMutiply-fortified saltSalt fortified with iron, zinc, vitamin B12, folic acid, and iodine
DIETARY_SUPPLEMENTIodized saltSalt fortified with iodine

Timeline

Start date
2022-10-17
Primary completion
2024-05-02
Completion
2024-05-02
First posted
2021-12-22
Last updated
2024-05-03

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT05166980. Inclusion in this directory is not an endorsement.